Ausgabe 2/2012
Inhalt (11 Artikel)
Investigating the Signal Transduction Pathways Underlying Remote Ischemic Conditioning in the Porcine Heart
D. J. Hausenloy, E. K. Iliodromitis, I. Andreadou, A. Papalois, G. Gritsopoulos, M. Anastasiou-Nana, D. T. Kremastinos, D. M. Yellon
Modulatory Effect of Fenofibrate on Endothelial Production of Neutrophil Chemokines IL-8 and ENA-78
Elvin Tyrone Price, Gregory James Welder, Issam Zineh
Fenoterol Enantiomers Do Not Possess Beneficial Therapeutic Properties of Their Racemic Mixture in the Rat Model of Post Myocardial Infarction Dilated Cardiomyopathy
Ismayil Ahmet, Tia Turner, Edward G. Lakatta, Mark I. Talan
In Vivo and In Vitro Protective Effects of Pentamethylquercetin on Cardiac Hypertrophy
Ting He, Lei Chen, Yong Chen, Yi Han, Wei-Qin Yang, Man-Wen Jin
Effects of HMG-CoA Reductase Inhibitor on Experimental Autoimmune Myocarditis
Xiaoman Liu, Bo Li, Wenke Wang, Cheng Zhang, Mingxiang Zhang, Yun Zhang, Yanfei Xia, Zhe Dong, Yuan Guo, Fengshuang An
Effects of Candesartan on Left Ventricular Function, Aldosterone and BNP in Chronic Heart Failure
Aneta Aleksova, Serge Masson, Aldo P. Maggioni, Donata Lucci, Renato Urso, Lidia Staszewsky, Stefano Ciaffoni, Giuseppe Cacciatore, Gianfranco Misuraca, Michele Gulizia, Lucio Mos, Gianni Proietti, Calogero Minneci, Roberto Latini, Gianfranco Sinagra
Antihypertensive Response to Thiazide Diuretic or Angiotensin Receptor Blocker in Elderly Hypertensives Is Not Influenced by Pretreatment Plasma Renin Activity
Howard S. Weintraub, Daniel A. Duprez, William C. Cushman, Dion H. Zappe, Das Purkayastha, Rita Samuel, Joseph L. Izzo Jr
Hypertension in the US Black Population: Risk Factors, Complications, and Potential Impact of Central Aortic Pressure on Effective Treatment
Keith C. Ferdinand, Raymond R. Townsend
Systematic Review and Meta-analysis of the Efficacy of Cardioversion by Vernakalant and Comparators in Patients with Atrial Fibrillation
Lori D. Bash, Jessica L. Buono, Glenn M. Davies, Amber Martin, Kyle Fahrbach, Hemant Phatak, Ruzan Avetisyan, Mkaya Mwamburi
ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies
Stephen J. Nicholls, Allan Gordon, Jan Johannson, Christie M. Ballantyne, Philip J. Barter, H. Bryan Brewer, John J. P. Kastelein, Norman C. Wong, Marilyn R. N. Borgman, Steven E. Nissen
Statin Treatment for All Individuals With Cholesterol Concentrations Above “Target”?
J. C. Kaski